OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma
Yang Song, Harry Cheuk-Hay Lau, Xiang Zhang, et al.
Cancer Biology and Medicine (2023), pp. 1-19
Open Access | Times Cited: 12

Showing 12 citing articles:

Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment
Jingjing Yu, Xiaoping Chen, Xiangliang Yang, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 11, pp. 1006-1020
Open Access | Times Cited: 8

Antibiotic-induced gut dysbiosis: unraveling the gut-heart axis and its impact on cardiovascular health
Navpreet Kaur, Pankaj Kumar, Mahadev Dhami, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications
Mario Romeo, Marcello Dallio, Filadelfo Nardo, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 124-124
Open Access

Cholelithiasis, Gut Microbiota and Bile Acids after Bariatric Surgery—Can Cholelithiasis Be Prevented by Modulating the Microbiota? A Literature Review
Natalia Komorniak, Jan Pawlus, Katarzyna Gaweł, et al.
Nutrients (2024) Vol. 16, Iss. 15, pp. 2551-2551
Open Access | Times Cited: 3

Altered intestinal Streptococcus anginosus and 5α-reductase gene levels in patients with hepatocellular carcinoma and elevated Bacteroides stercoris in atezolizumab/bevacizumab non-responders
Tadashi Fujii, Teiji Kuzuya, Nobuhiro Kondo, et al.
Journal of Medical Microbiology (2024) Vol. 73, Iss. 9
Closed Access | Times Cited: 2

Modulation of Gut Microbial Biomarkers and Metabolites in Cancer Management by Tea Compounds
Hoi Kit Matthew Leung, Emily Kwun Kwan Lo, Fangfei Zhang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6348-6348
Open Access | Times Cited: 1

Bile Acids and Liver Cancer: Molecular Mechanism and Therapeutic Prospects
Xuemei Zhang, Lei Shi, Xiaona Lu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1142-1142
Open Access

Gut microbiota-mediated bile acid metabolism aggravates biliary injury after liver transplantation through mitochondrial apoptosis
Lu Wang, Zipei Wang, Yuanyuan Zhao, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113413-113413
Closed Access

Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development
Nevena Todorović, Serena Martinelli, Giulia Nannini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13510-13510
Open Access

Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma?
Kin Lam Yu, Sj Shen
European Journal of Cancer (2024) Vol. 216, pp. 115195-115195
Open Access

Page 1

Scroll to top